Overview | Medtronic

Creating Long-Term Shareholder Value

Medtronic is uniquely positioned to create long-term value in healthcare. The combination of Medtronic and Covidien creates a robust, market-leading medical technology and services company with a comprehensive product portfolio, broad geographic reach, and diversified growth profile. We believe Covidien meaningfully complements and accelerates our three primary strategies - therapy innovation, globalization, and economic value. We are focused on delivering a strong launch cadence of leading healthcare innovation, addressing the inequity in healthcare access globally, and becoming a leader in the changing value-based healthcare landscape with offerings that deliver both clinical and economic value to a broader set of partners around the world, including physicians, hospital systems, payers, governments, and patients. The addition of Covidien is expected to not only strengthen our long-term market competitiveness, but also increase our financial strength and capital deployment flexibility, driving further sustainability and consistency in our long-term performance. We believe that execution and reliable performance, combined with our disciplined allocation of capital, will create long-term value for our shareholders.

Latest Investor Information

April 15, 2015
Shareholders still holding Medtronic, Inc. certificates or Direct Registered Accounts at Wells Fargo Shareowner Services - You will not receive your dividend payments on your Medtronic plc holdings until you exchange your shares. Click here for more info.
March 11, 2015
Medtronic plc at the Barclays Global Healthcare Conference

Latest Press Releases

May 06, 2015Medtronic to Unveil First-of-Its-Kind Clinical Data for Cardiac Therapies at Heart Rhythm 2015
May 05, 2015Medtronic Announces FDA Clearance and U.S. Launch of the Euphora(TM) Semicompliant Coronary Balloon
May 04, 2015Medtronic Announces Launch of DIVERGENCE(TM) Stand Alone Interbody Cage
May 04, 2015Medtronic Receives FDA Clearance for ZEVO(TM) Anterior Cervical Plate System
Read More

Sustainability Index Endorsements

Read more about our Sustainability efforts.


Medtronic Spotlight

AdvaMed’s Lifetime Achievement Award tribute to Medtronic founder Earl Bakken.

Play Video

Focus on Patients

The personal connection between Medtronic plc, its employees and patients.

Play Video

History of Medtronic

A video history of the company.

Play Video

Investor Contacts

Stock Transfer Agent

Wells Fargo Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department


+1 763-505-2692

Jeff Warren

Vice President, Investor Relations

Ryan Weispfenning

Senior Director, Investor Relations

View All